D.A. Davidson & Co’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
90,600
-1,250
| -1% | -$14.6K | 0.01% | 799 |
|
|
2025
Q1 | $682K | Buy |
91,850
+3,400
| +4% | +$25.3K | 0.01% | 905 |
|
|
2024
Q4 | $530K | Buy |
88,450
+6,725
| +8% | +$40.3K | ﹤0.01% | 989 |
|
|
2024
Q3 | $418K | Sell |
81,725
-4,500
| -5% | -$23K | ﹤0.01% | 1082 |
|
|
2024
Q2 | $312K | Buy |
86,225
+28,100
| +48% | +$102K | ﹤0.01% | 1148 |
|
|
2024
Q1 | $187K | Buy |
58,125
+11,150
| +24% | +$35.8K | ﹤0.01% | 1298 |
|
|
2023
Q4 | $230K | Sell |
46,975
-6,900
| -13% | -$33.8K | ﹤0.01% | 1200 |
|
|
2023
Q3 | $294K | Sell |
53,875
-29,400
| -35% | -$160K | ﹤0.01% | 1093 |
|
|
2023
Q2 | $559K | Buy |
83,275
+29,550
| +55% | +$198K | 0.01% | 891 |
|
|
2023
Q1 | $474K | Buy |
53,725
+15,325
| +40% | +$135K | 0.01% | 909 |
|
|
2022
Q4 | $293K | Sell |
38,400
-3,150
| -8% | -$24.1K | ﹤0.01% | 1052 |
|
|
2022
Q3 | $296K | Buy |
41,550
+1,385
| +3% | +$9.87K | ﹤0.01% | 1008 |
|
|
2022
Q2 | $325K | Buy |
40,165
+15,370
| +62% | +$124K | ﹤0.01% | 975 |
|
|
2022
Q1 | $344K | Buy |
24,795
+6,850
| +38% | +$95K | ﹤0.01% | 1019 |
|
|
2021
Q4 | $504K | Buy |
17,945
+1,160
| +7% | +$32.6K | 0.01% | 874 |
|
|
2021
Q3 | $571K | Buy |
16,785
+875
| +5% | +$29.8K | 0.01% | 794 |
|
|
2021
Q2 | $650K | Buy |
15,910
+525
| +3% | +$21.4K | 0.01% | 756 |
|
|
2021
Q1 | $619K | Buy |
15,385
+4,750
| +45% | +$191K | 0.01% | 735 |
|
|
2020
Q4 | $629K | Sell |
10,635
-100
| -0.9% | -$5.91K | 0.01% | 629 |
|
|
2020
Q3 | $522K | Sell |
10,735
-280
| -3% | -$13.6K | 0.01% | 601 |
|
|
2020
Q2 | $533K | Sell |
11,015
-5,375
| -33% | -$260K | 0.01% | 576 |
|
|
2020
Q1 | $455K | Buy |
16,390
+3,120
| +24% | +$86.6K | 0.01% | 615 |
|
|
2019
Q4 | $397K | Buy |
+13,270
| New | +$397K | 0.01% | 737 |
|